Hyperprolactinemia in Renal Failure: Mechanisms and Clinical Impact

Renal failure commonly causes hyperprolactinemia (elevated prolactin) through multiple pathways:

  1. Reduced Prolactin Clearance: Kidneys degrade/clear prolactin; impaired function → accumulation.
  2. Increased Prolactin-Releasing Factors: Altered renal production of factors stimulating pituitary prolactin release.
  3. Dopamine Metabolism Disruption: Dopamine inhibits prolactin; uremia impairs dopamine clearance/synthesis → reduced inhibition.
  4. Elevated Estrogen: Impaired estrogen clearance → stimulates prolactin secretion (esp. in women).
  5. Hypothalamic-Pituitary-Thyroid Axis Dysfunction: Uremia disrupts hypothalamic-pituitary regulation.
  6. Medication Effects: Some renal meds (certain antipsychotics, metoclopramide, verapamil) raise prolactin.

Clinical Consequences

  • Menstrual irregularities, anovulation, infertility
  • Galactorrhea
  • Low libido, sexual dysfunction (both sexes)
  • Osteoporosis risk (via hypogonadism)

Management

  • Optimize dialysis adequacy
  • Review/adjust offending medications
  • Treat underlying thyroid dysfunction
  • Dopamine agonists (cabergoline, bromocriptine) if symptomatic—caution in ESRD
  • Multidisciplinary: nephrology, endocrinology, gynecology/urology

Kidney Disease - Related Articles